GlassScriptPhysician profile
Ciera M Briggs
NPI 1760146534
$7,609.88
in general payments reported to CMS, 2019-2025
14 companies · $1,965 in 2025
The $1,965 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.98 · 2022: $460 · 2023: $360 · 2024: $4,791 · 2025: $1,965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,680 · Travel and Lodging: $3,426 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,680.09 |
| Travel and Lodging | $3,426.34 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,114.94 | 2022-2025 | Micra, Linq II, Mycarelink |
| Cvrx, INC. | $1,475.18 | 2024-2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $647.63 | 2021-2025 | |
| Pfizer INC. | $284.02 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $259.02 | 2022-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $227.35 | 2023-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $132.77 | 2022-2024 | Farxiga |
| Merck Sharp & Dohme LLC | $107.36 | 2022-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.71 | 2024-2025 | Lifevest |
| Amgen INC. | $85.54 | 2022-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $78.67 | 2022-2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $40.28 | 2023 | Inpefa |
| Kiniksa Pharmaceuticals, LTD. | $33.03 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $21.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ciera Briggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.